Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15501 - 15525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	SNCA	6622	upregulated	Bortezomib results in increased expression of SNCA mRNA	4q22.1	A21438
Bortezomib	Approved Investigational	SNRNP48	154007	upregulated	Bortezomib results in increased expression of SNRNP48 mRNA	6p24.3	A21434
Bortezomib	Approved Investigational	SOCS3	9021	upregulated	Bortezomib results in increased expression of SOCS3 mRNA	17q25.3	A21434
Bortezomib	Approved Investigational	SOCS5	9655	upregulated	Bortezomib results in increased expression of SOCS5 mRNA	2p21	A21434
Bortezomib	Approved Investigational	SPATA5	166378	upregulated	Bortezomib results in increased expression of SPATA5 mRNA	4q28.1	A21434
Bortezomib	Approved Investigational	SPN	6693	downregulated	Bortezomib results in decreased expression of SPN mRNA	16p11.2	A21434
Bortezomib	Approved Investigational	SPP1	6696	downregulated	Bortezomib results in decreased expression of SPP1 mRNA	4q22.1	A20714 A21451
Bortezomib	Approved Investigational	SPSB3	90864	upregulated	Bortezomib results in increased expression of SPSB3 mRNA	16p13.3	A21434
Bortezomib	Approved Investigational	SPTBN1	6711	upregulated	Bortezomib results in increased expression of SPTBN1 mRNA	2p16.2	A21434
Bortezomib	Approved Investigational	SPTY2D1	144108	upregulated	Bortezomib results in increased expression of SPTY2D1 mRNA	11p15.1	A21434
Bortezomib	Approved Investigational	SQSTM1	8878	upregulated	Bortezomib results in increased expression of SQSTM1 mRNA	5q35.3	A21434
Bortezomib	Approved Investigational	SRRT	51593	downregulated	Bortezomib results in decreased expression of SRRT mRNA	7q22.1	A21434
Bortezomib	Approved Investigational	SRSF1	6426	downregulated	Bortezomib results in decreased expression of SRSF1 mRNA	17q22	A21434
Bortezomib	Approved Investigational	SSRP1	6749	downregulated	Bortezomib results in decreased expression of SSRP1 mRNA	11q12.1	A21434
Bortezomib	Approved Investigational	STIM2	57620	downregulated	Bortezomib results in decreased expression of STIM2 mRNA	4p15.2	A21434
Bortezomib	Approved Investigational	STIP1	10963	downregulated	Bortezomib results in decreased expression of STIP1 mRNA	11q13.1	A21434
Bortezomib	Approved Investigational	STIP1	10963	upregulated	Bortezomib results in increased expression of STIP1 mRNA	11q13.1	A21438
Bortezomib	Approved Investigational	STS	412	downregulated	Bortezomib results in decreased expression of STS mRNA	Xp22.31	A21434
Bortezomib	Approved Investigational	STX12	23673	upregulated	Bortezomib results in increased expression of STX12 mRNA	1p35.3	A21434
Bortezomib	Approved Investigational	STYK1	55359	upregulated	Bortezomib results in increased expression of STYK1 mRNA	12p13.2	A21434
Bortezomib	Approved Investigational	SUDS3	64426	upregulated	Bortezomib results in increased expression of SUDS3 mRNA	12q24.23	A21434
Bortezomib	Approved Investigational	SUMO1	7341	upregulated	Bortezomib results in increased expression of SUMO1 mRNA	2q33.1	A21434
Bortezomib	Approved Investigational	SUSD4	55061	downregulated	Bortezomib results in decreased expression of SUSD4 mRNA	1q41	A21434
Bortezomib	Approved Investigational	SUV39H1	6839	downregulated	Bortezomib results in decreased expression of SUV39H1 mRNA	Xp11.23	A21437
Bortezomib	Approved Investigational	SVOPL	136306	downregulated	Bortezomib results in decreased expression of SVOPL mRNA	7q34	A21434

Displaying entries 15501 - 15525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability